Compare VANI & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | RBA |
|---|---|---|
| Founded | 1998 | 1958 |
| Country | United States | United States |
| Employees | N/A | 8000 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0M | 19.0B |
| IPO Year | 2014 | N/A |
| Metric | VANI | RBA |
|---|---|---|
| Price | $1.30 | $106.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.50 | ★ $122.20 |
| AVG Volume (30 Days) | 184.4K | ★ 1.0M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,000,000.00 | N/A |
| Revenue This Year | N/A | $4.43 |
| Revenue Next Year | N/A | $6.65 |
| P/E Ratio | ★ N/A | $52.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $93.58 |
| 52 Week High | $1.92 | $119.58 |
| Indicator | VANI | RBA |
|---|---|---|
| Relative Strength Index (RSI) | 60.62 | 58.73 |
| Support Level | $1.24 | $106.26 |
| Resistance Level | $1.34 | $109.55 |
| Average True Range (ATR) | 0.06 | 2.54 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 100.00 | 86.22 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.